Clinical Trial Update: Dichloroacetate (DCA) for the Treatment of Pulmonary Arterial Hypertension [Phase 1]

View source ↗

Summary

Phase 1 clinical trial evaluating dichloroacetate (DCA) for pulmonary arterial hypertension has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pulmonary Arterial Hypertension

Drugs mentioned

• Dichloroacetate (DCA) (dichloroacetate)

Snippet

Sponsor: University of Alberta | Conditions: Pulmonary Hypertension (Idiopathic, Familial or Anorexigen-associated) | Phase 1 | Status: COMPLETED